342 related articles for article (PubMed ID: 8712071)
1. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.
Hall M; Peters G
Adv Cancer Res; 1996; 68():67-108. PubMed ID: 8712071
[No Abstract] [Full Text] [Related]
2. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
3. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
Lee YM; Sicinski P
Cell Cycle; 2006 Sep; 5(18):2110-4. PubMed ID: 16969111
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
5. p16INK4 mutations and altered expression in human tumors and cell lines.
Okamoto A; Demetrick DJ; Spillare EA; Hagiwara K; Hussain SP; Bennett WP; Forrester K; Gerwin B; Greenblatt MS; Serrano M
Cold Spring Harb Symp Quant Biol; 1994; 59():49-57. PubMed ID: 7587103
[No Abstract] [Full Text] [Related]
6. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
[TBL] [Abstract][Full Text] [Related]
7. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
[TBL] [Abstract][Full Text] [Related]
8. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
Vikhanskaya F; Erba E; D'Incalci M; Broggini M
Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
[TBL] [Abstract][Full Text] [Related]
9. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
Hunter T; Pines J
Cell; 1994 Nov; 79(4):573-82. PubMed ID: 7954824
[No Abstract] [Full Text] [Related]
10. Staurosporine-induced growth inhibition of glioma cells is accompanied by altered expression of cyclins, CDKs and CDK inhibitors.
Harmalkar MN; Shirsat NV
Neurochem Res; 2006 May; 31(5):685-92. PubMed ID: 16770740
[TBL] [Abstract][Full Text] [Related]
11. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
Ellis M; Chew YP; Fallis L; Freddersdorf S; Boshoff C; Weiss RA; Lu X; Mittnacht S
EMBO J; 1999 Feb; 18(3):644-53. PubMed ID: 9927424
[TBL] [Abstract][Full Text] [Related]
12. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
[TBL] [Abstract][Full Text] [Related]
13. Cyclins and related kinases in cancer cells.
Malumbres M
J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
[TBL] [Abstract][Full Text] [Related]
14. Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer.
Musgrove EA; Lilischkis R; Cornish AL; Lee CS; Setlur V; Seshadri R; Sutherland RL
Int J Cancer; 1995 Nov; 63(4):584-91. PubMed ID: 7591270
[TBL] [Abstract][Full Text] [Related]
15. Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus.
Altucci L; Addeo R; Cicatiello L; Germano D; Pacilio C; Battista T; Cancemi M; Petrizzi VB; Bresciani F; Weisz A
Endocrinology; 1997 Mar; 138(3):978-84. PubMed ID: 9048598
[TBL] [Abstract][Full Text] [Related]
16. How cells cycle toward cancer.
Marx J
Science; 1994 Jan; 263(5145):319-21. PubMed ID: 8278804
[No Abstract] [Full Text] [Related]
17. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
Wilcken NR; Sarcevic B; Musgrove EA; Sutherland RL
Cell Growth Differ; 1996 Jan; 7(1):65-74. PubMed ID: 8788034
[TBL] [Abstract][Full Text] [Related]
19. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.
Sgambato A; Han EK; Zhang YJ; Moon RC; Santella RM; Weinstein IB
Carcinogenesis; 1995 Sep; 16(9):2193-8. PubMed ID: 7554074
[TBL] [Abstract][Full Text] [Related]
20. Cell-cycle regulators and cancer.
Kamb A
Trends Genet; 1995 Apr; 11(4):136-40. PubMed ID: 7732591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
